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ABSTRACT 
Although osteoporosis in elderly is increasingly recognized as an important health issue, 
there remain few comprehensive studies concerning the etiology of osteoporosis and 
determinants of bone mineral density (BMD) in the Chinese. Using peripheral quantitative 
computed tomography (pQCT), we assessed trabecular and cortical bone density, and 
geometric distribution at the radius and tibia in 346 and 316 Chinese men and women 
respectively, aged 20-94 years, recruited from the population living in Hong Kong. Total, 
trabecular and cortical bone density declined with age in both sexes, and the rate of 
deterioration was much faster in women than in men. The total and trabecular bone area 
expanded with age, but the extent of enlargement was greater in men. For men, the cortical 
bone area decreased with age slightly whereas women had significantly smaller cortical bone 
area. The moment of inertia was relatively stable with age in men compared with women. 
With the enlargement of bone cross-sectional area, the declining bone density was 
compensated and bone strength can be reserved. 
To determine the correlating factors of bone density in old Chinese, 428 men and 424 
women 65 years of age or older were studied. Medical and lifestyle information was obtained 
by interview and anthropometric data by examination. Radial and tibial pQCT was measured 
using pQCT. In multivariate models, weight, a history of diabetes and hypertension and 
intake of cardiac drugs were related to higher trabecular bone density; whereas age, previous 
history of fracture and gastrectomy were associated with lower density and intake of 
corticosteroid were related to declining cortical bone density. These data may help in the 
clinical identification of elders at higher risk of osteoporosis. 
For the development of a long-term precision, and high reproducibility bone 
histomorphometry to monitor bone mineral density, we had investigated the performance of 
peripheral and central bone densitometries in discriminating between fracture and 
non-fracture cases in 356 men and 313 women, 65 years of age or older. All subjects had 
bone measurements at radius and tibia on pQCT and dual energy X-ray absorptiometry (DXA) 
at total hip and femoral neck. Both DXA and pQCT had limited predictive power for incident 
fracture; the only significant parameter was radial trabecular BMD (AUC 0.649). 
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CHAPTER 1 
INTRODUCTION 
Osteoporosis is the most common generalized disease of the skeleton, causing reduction 
of bone mass and changes in bone structure. The loss of integrity of the trabecular network 
and the cortical shell result in a reduction in bone strength and in fragility fractures. The 
strength of bone tissue is proportional to the apparent density of the bone mineral that it 
contains. Current methods for evaluating skeletal status, assessing osteoporosis, and 
determining fracture risk rely mostly on the noninvasive measurement of bone mineral 
content (BMC) and bone mineral density (BMD) (Genant and Jiang, 2007; Grampp et al., 
1993). Of these methods, peripheral quantitative computed tomography (pQCT) is becoming 
a popular device to determine volumetric BMD of the peripheral skeleton, as it measures the 
true three-dimensional BMD (vBMD in mg/cm^) of trabecular and cortical bone separately 
(Gluer et al., 1997; Qin et al., 2000; Qin et al., 2002; Genant and Jiang, 2007). 
The etiology of osteoporotic fractures is complex and multi-factorial. Nevertheless, bone 
mass is a major determinant. There remain few data concerning the determinants of bone 
mass in men, especially in Asian population. Again, an age-related increase in the rate of 
falling and a concomitant decrease in bone mass both undoubtedly contribute to fracture risk, 
but little are known concerning the pathophysiology of either falls or osteopenia in men. 
In the current study, BMD data from pQCT and relevant bone mass-determining 
variables, such as weight, height, and physical activity, would be collected from the subjects. 
Besides, trabecular and cortical bone loss at different sites and its relations with risk factors 
would also be determined. These data will be useful to delineate the relationship between a 
host of physical and lifestyle factors with bone mineral density in the elderly. 
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Purpose of the study 
The aim of this study was to examine the performance of pQCT in identification of 
osteoporosis for the Chinese population in clinical practice. 
Specific objectives of this study were: 
(1) To study the relationship between age and volumetric BMD and geometric distribution of 
bone in Chinese male and female; 
(2) To delineate the relationship between a host of physical and lifestyle factors with vBMD 
in two genders; 
(3) To demonstrate the ability of the two techniques, that is pQCT and dual energy x-ray 
absorptiometry (DXA), in differentiating between fracture and non-fracture subjects and 
their ability to predict future fracture. 
Hypotheses 
Hypotheses of the present study were as follows: 
1. Rate of deterioration in trabecular and cortical bones at peripheral skeletal sites were 
faster in female. 
2. Correlating risk factors of vBMD in trabecular and cortical bones were the same in both 
sexes. 
3. pQCT had better performance than DXA in discriminating between fracture and 
non-fracture cases. 
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CHAPTER 2 
LITERATURE REVIEW 
Peripheral QCT was developed as a small-field; high resolution extension of the existing 
quantitative computed tomography (QCT) systems to measure the peripheral skeleton with a 
substantial improvement of the image definition. Many bone variables in human long bones 
can be measured by pQCT including trabecular and cortical bone density, respective 
cross-sectional area, bone strength index and bone mineral content. Non-invasive bone 
densitometry is commonly used in clinical settings to assess bone density and the efficacy of 
treatment for osteoporosis. DXA or pQCT have been used to make such determinations. 
These techniques differed in their measurement parameters, types of data collected, and mode 
of bone density calculations. 
DXA was considered to be the "benchmark" method of assessing bone mineral density. 
It offers excellent precision, reasonable accuracy, flexibility in applications, short 
examination time with low radiation exposure to patients and the ability to predict the 
fracture risk (Genant et al., 1996; Johnson and Dawson-Hughes, 1991; Marshall et a l , 1996). 
However, the inherent planar nature of the measurement restricted the utility of the areal bone 
mineral density (Genant et al., 1996). Furthermore, DXA measurement is unable to 
discriminate between trabecular and cortical bones, which are known to show different 
responses to aging and treatment (Gatti et al., 1996; Rico et al., 1994; Ruegsegger et al., 
1995). Although QCT could cope with this limitation, high costs and technical requirements 
of the instrument in conjunction with the large radiation exposure to the patient restrained the 
practicability. 
The development of pQCT allows a thorough assessment of skeletal status at the 
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extremities (Sievanen et al.，1998). It has the advantage of measuring the volumetric, not 
areal, BMD which overcomes the projectional limitations of DXA. pQCT also allows a 
separate measurement of trabecular and cortical bone in peripheral skeletal sites with higher 
precision (Genant et al., 1996; Ito et al.，1997). This is advantageous because these two types 
of bones have distinct remodeling characteristics (Eriksen et al., 1993) that reflect differences 
in metabolic activity (Vaughan, 1975). Moreover, cross-sectional images provide further 
information about geometrical parameters of bone for noninvasive assessments of mechanical 
strength. Besides this, pQCT has advantages over QCT with lower radiation dose and cost, 
higher precision (Augat et al., 1998; Guglielmi et al., 1997) and a higher predictive ability for 
fractures at peripheral skeletal sites (Augat et al., 1998). 
The validity of volumetric bone density measurement of the distal radius for the 
evaluation of age-related bone loss and for the diagnosis of osteoporosis has been proven 
(Hasegawa et al., 1997) and many studies were carried out to investigate the BMD changes in 
radius among premenopausal and postmenopausal women (Qin et al., 2002; Russo et al., 
2003). To our knowledge, the bone density of upper limbs was different from that of lower 
limbs under mechanical effect. In addition, pQCT measurements of cortical and trabecular 
bone density in the upper limbs differed significantly as a result of greater activity in the 
dominant limb (Rico et al., 1994). However, only a few studies have been focused on the 
changes of bone structure and density in lower limbs (Ruff and Hayes, 1988), especially in 
Asia. Therefore, there is a need to collect the normative data on the age-related changes of 
both upper and lower limbs by pQCT in the Chinese elderly for future reference purposes in 
clinical or research practice. 
Patients with osteoporosis were usually without symptoms which contribute to 
under-diagnosing of this potentially devastating condition. It was estimated that less than half 
of patients with osteoporosis are diagnosed in many developed countries (Kulenovic et al., 
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2006). Therefore, preventive measures and timely diagnosis have to be a key aspect of 
management of this disorder. Although BMD is the standard test for the diagnosis of 
osteoporosis, bone density measurement alone is insufficient for assessing fracture risk and 
treatment efficacy as many risk factors contribute to the development of osteoporosis and 
increase the fracture risk. Clinical risk factors play an important role in assessing the risk of 
developing osteoporosis and in determining who should be treated. In fact, numerous studies 
on risk factors of osteoporosis have been done using DXA (Lau et al.，2006; Orwoll et al., 
2000). However there have been no studies focusing on the determinants of declining 
trabeulcar and cortical bone density in Chinese elderly, yet the two types of bones were 
heterogeneous and showed different responses to aging (Ninomiya et al., 1990). It is therefore 
of clinical importance to evaluate the relationship between anthropometric, lifestyle, medical 
and other factors with BMD of trabecular and cortical bones respectively in the prognosis of 
osteoporosis. 
Osteoporosis has clinical and public health importance only because of fractures which 
attributes to bone weakening and the declining of neuromuscular function as a result of aging. 
Osteoporotic fractures are one of the most common causes of disability and a major 
contributor to medical care costs in many regions of the world. Also, the risk of a fracture 
would further increase independently after an osteoporotic fracture (Klotzbuecher et al., 2000; 
Silman, 1995; Wasnich et al., 1994)，however, the risk of a second fracture was critically 
dependent on BMD as well (Ross et al., 1991). The social burden of fractures would increase 
throughout the world as the population ages. In order to identify high-risk individuals for 
prevention and prediction of fractures, it is therefore important to know the degree of 
reduction in bone density in patients who have already suffered a fracture. It seems possible 
that there may be differences in BMD between trabecular and cortical bone of fracture 
patients as there are in normal aging process. pQCT measurement of the two types of bones 
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at peripheral skeleton and DXA measurements of axial skeleton enable the comparison of 
sensitivity in predicting fractures between the two densitometries. The use of pQCT 
measurements at the distal radius have been shown to be useful for the diagnosis of 
osteoporosis and for predicting the risk of spinal and hip fractures (Augat et al., 1996; 
Schneider and Bomer, 1990). However, some studies found that pQCT has poor ability to 
discriminate patients with fractures and appeared to be less sensitive than measurements 
using DXA (Formica et al., 1998; Boonen et al, 1997). Other findings reported that pQCT 
measurement was difficult to predict changes in axial skeleton as a result of the weak 
relationship between appendicular and axial bone density (Tsumsaki et al.，2000; Sievanen et 
al., 1998; Gardsell et al., 1989). Nevertheless, the achievement in the prediction of spine or 
hip fractures by measurements at remote sites or the improvement of predictive ability by 
measurements at multiple sites could potentially increase the success of osteoporosis 
screening programs. 




Subjects in the current study were from three projects, namely Aerobic Capacity of 
Apparently Healthy Hong Kong Population, 'Mr Os' and 'Ms Os，，which carried out 
previously. 
Aerobic Capacity of Apparently Healthy Hong Kong Population 
178 Chinese male and 207 Chinese female subjects of age 20-65 years were recruited 
from the community by pamphlets distribution and telephone calls. The objective of the study 
was to provide normative data on maximal cardiorespiratory function for healthy Hong Kong 
Chinese. Therefore, subjects with previous history of cardiopulmonary disease were excluded 
from the study. Demographic data together with heart rate, blood pressure, cardio-respiratory 
measurements and bone mineral parameters measured with pQCT were collected. The 
Physical Activity Readiness Questionnaire (PAR-Q & You) was used to evaluate the health of 
each individual and those patients with cardiac symptoms on exertion, with history of 
uncontrolled hypertension or with severe osteoarthritis were excluded. Graded exercise 
testing was performed with the subject sitting on a bicycle ergometer, wearing a facemask 
that connected to the metabolic cart for gas analysis. ECG and blood pressure were monitored 
during the entire exercise test. 
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Mr Os and Ms Os 
The Osteoporotic Fractures in Men Study, ‘Mr Os，and The Osteoporotic Fractures in 
Women Study, ‘Ms Os, were a large cohort study on osteoporosis in Asian men and women. 
2000 Hong Kong Chinese male and female with age 65 or above were recruited between 
January 2001 and December 2003 respectively. Stratified sampling was used in order to 
obtain approximately one-third of the subjects in each of the following age groups: 65-69, 
70-74 and > 75 years. All subjects were recruited through public advertising from community 
centers, newspapers and supplemented by visits to housing communities in the districts 
surrounding the research centre. Subjects who had bilateral hip replacements and who cannot 
walk independently were excluded. Subjects were invited to the research centre for 
interviews and examinations for three times in 2-year intervals. Informed consent was 
obtained on a one-to-one basis. Detailed data on the lifestyle risk factors for osteoporosis 
(such as diet, physical activity, mental status, cigarette smoking, alcohol consumption and fall 
and fracture history), medical factors (including diseases and medications), anthropometric 
data (like body weight, height and body mass index) and bone mineral density at the hip by 
DXA were obtained at baseline examination. The follow-up examination included repeated 
measures of bone mineral density by DXA, and measures of change in health and functional 
status. In addition, participants were followed up every four months by phone to obtain 
history on fracture, falls and other major medical events. The objectives of MrOs and MsOs 
study were to define how lifestyle, anthropometric, physical and medical factors were related 
to bone loss and falls in the Chinese elderly, to use international standardized methods to 
compare the age-specific prevalence and incidence of vertebral fracture in Hong Kong and 
the United States, to compare the predictors of vertebral fracture in Chinese elderly to 
Caucasian elderly, and to examine the effects of vertebral fracture on health and quality of 
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life. 
Among 4000 subjects, 428 male and 424 female had trabecular and cortical BMD 
measured with pQCT at baseline examination, and they were included in the current study. 
Recruitment of subjects 
(a) Relationship between age and vBMD for the Chinese population using pQCT 
We recruited subjects from an age-stratified, random sample of the three projects 
mentioned above, namely Aerobic Capacity of Apparently Healthy Hong Kong Population, 
'Mr Os' and ‘Ms Os'. In order to ensure the number of samples in each age group were of 
comparable size, subjects from ‘Mr Os，and 'Ms Os' were randomly selected. The sample 
spanned ages from 20 to 94 years and included 346 males and 316 females. To avoid 
confusion, a simplified flow chart was shown in Figure 1. 
Mr Os, Aged>65 Ms Os, Aged>65 
n=2000 n=2000 
Randomly selected — 
Aerobic Capacity of 
Mr Os, Aged>65 Ms Os, Agecl>65 Apparently Healthy 




Selected as subjects for 
part (A), Aged from 20-94 
n= 346 male, 316 female 
Fig. 1 Inclusion of subjects for part (A) Relationship between age and vBMD for the Chinese 
population using pQCT 
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(b)Risk factors of vBMD in peripheral sites 
Subjects in this part of study were from the two projects, namely ‘Mr Os' and ‘Ms Os，， 
which consist of 428 men and 424 women who received pQCT measurements at baseline 
examination (Fig 2). 
(c) Performance ofpQCT and DXA on fracture discrimination 
428 men and 424 women who had participated in the MrOs and MsOs study were 
included in this part of study. All of them received measurements of radius and tibia on pQCT 
and DXA of total hip and femoral neck at the baseline examination. Eighteen men and 
fifty-one women were subsequently excluded because they were receiving bisphosphate 
treatment, leaving 410 men and 373 women eligible to continue the study. Subsequently, 31 
men and 45 women withdrew from the study during the first four years and 23 men and 15 
women who died were also excluded, leaving 356 men and 313 women who were then 
followed for 4 years. The analysis of fracture incidence presented here included the 356 men 
(83.2 percent) and 313 women (73.8 percent) who continued to participate throughout the 
study period (Fig 2). 
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Fig. 2 Inclusion of subjects for part (B) Risk factors for vBMD in peripheral sites & part (C) 
Performance ofpQCT and DXA on fracture discrimination 
Subjects inclusion and exclusion criteria for the study 
Subjects receiving osteoporotic medication, such as estrogen therapy and bisphosphate 
therapy were excluded. Elderly subjects who had had bilateral hip replacements or who were 
unable to walk without assistance of another person were also excluded. In addition, subjects 
who died and were unable to finish the study would also be excluded as the information 
collected on telephone in 4-month intervals was uncertain. 
All subjects were given a written informed consent before the study (appendix A, B). 
The study was approved by the Clinical Research Ethics Committee of the Chinese 
University of Hong Kong. 
Interview and questionnaire 
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All subjects from MrOs and MsOs study completed an interview-based osteoporosis risk 
factors questionnaire (appendix C, D)，which was standardized and structured that covered 
the following aspects: 
Anthropometric measurements 
Body weight and height were measured, with subjects wearing a light gown without 
shoes, by the Physician Beam Balance Scale (Healthometer, Illinois, USA) and the Holtain 
Harpenden standiometer (Holtain Ltd, Crosswell, UK) respectively. Body mass index (BMI, 
kg/m ) was calculated using the formula, weight (kg)/ height (m) . Anthropometric 
measurements were recorded at the examination. Body composition was estimated by DXA. 
DXA measurements were performed using a whole body scanner (Hologic QDR-4500W 
densitometers; Hologic, Inc., Waltham, MA) employing fan beam and scanning at slow speed. 
Subjects lying in a supine position, dressed in light gown, without any metal items in their 
clothing or elsewhere. Fat-free soft tissue excluding bone (i.e., including muscle, body water, 
and internal organs), fat soft tissue, and bone mineral densities were measured. Whole body 
fat percentage (WBF %) was calculated by dividing fat soft-tissue mass with entire body 
mass, using the software supplied by the manufacturer. 
Overall health and medication 
A selected medical history was obtained, including stroke, diabetes, coronary heart 
disease, congestive heart failure, chronic obstructive pulmonary disease, thyroid disorder, 
gastrectomy or bowel resection and fracture history since age 50, based on the subjects' 
report of diagnoses as told by their doctors and counter-checked by their medications. They 
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were also asked to bring all current medications for recorded. 
Cigarette smoking and alcohol consumption 
Cigarette smoking and alcohol consumption were based on self-report (Chan et aL, 
1996). Information on past and current use of cigarettes was obtained. Smoking history was 
classified into former smoking, current smoking and never smoking. A detailed alcohol 
consumption history was also taken. Intake of wine, Chinese wine, beer and spirits were 
measured. A standard drink was defined as one which contained lOg of alcohol. 
Grip strength 
Grip strength was measured twice by a Preston Grip Dynamometer (Takei Kiki Kogyo) 
in both left and right arms. The average grip strength in kg was used in the analysis. 
Physical activity 
Physical activity was assessed using the validated Physical Activity Scale for the Elderly 
Questionnaire (PASE) (Washburn et al., 1993). It was adapted for use in Hong Kong Chinese 
elderly (Liu et al.,2001). 
Walking speed 
Walking speed was determined as usual time to complete a 6-meter course and 
expressed in meters per second. Two trials were performed. The average of the two trials was 
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taken. 
Assessment of fracture case 
Participants who reported fracture in on-site examination or on telephone were recorded. 
Also, we obtained information from Hospital Authority in half-year-interval. Reported 
fractures were confirmed and classified by a radiographer from radiographs or surgical 
reports. 
Incident fracture 
Besides recording fracture cases in on-site examination, participants were contacted 
every 4 months by telephone to enquire about fractures and information would also be 
obtained from Hospital Authority in half-year-interval for 4 years (appendix E). Only 7% 
men and 11% women were lost to follow-up. Participants receiving osteoporotic medication, 
such as estrogen therapy and bisphosphate therapy were excluded. Reported fractures were 
confirmed and classified following the same procedure mentioned in the previous part. 
Bone mineral density measurement 
pQCT measurement 
At the beginning of the measurement, the participants were asked which arm they use 
more frequent, the dominant arm was then excluded so as to minimize the effect of 
confounding factors, such as genetics, hormones, medications, nutrition, and other lifestyle 
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factors, on BMD (Lai et al., 2006). However, for lower limbs, the issue of domination should 
not have much effect as both limbs were assumed under the same effect of confounding 
factors that mentioned before. The trabecular and cortical volumetric BMD of the 
nondominant forearm and the opposite lower leg pQCT were measured, by a XCT 3000 
machine (Stratec Medizintechnik, Pforzheim, Germany) with an effective X-ray photon 
energy of 42 KeV. If a subject had a previous fracture at the measurement site, then the 
non-fractured limb was measured. The subjects seated in front of the apparatus with 
non-dominant forearm and opposite leg extended, positioned inside the gantry of the device. 
The high turnover trabecular BMD in a core volume (central 50% of the total bone area) and 
the integral BMD of cortical and trabecular bone in the total bone volume were measured 
separately and expressed as mg/cm^. Standard 2.5mm thick transverse scans were obtained at 
4 % and 33% of the limb length, where trabecular bone and cortical bone are distributed 
respectively. The coefficient of variation for the measurement at the distal radius and tibia 
trabecular bone were 2.49% and 0.89% respectively. For the measurement at the proximal 
radius and tibia cortical bone were 0.53% and 0.43% respectively. 
DXA measurement 
BMD of the total hip and the lumbar spine (L1-L4) was measured at the examination 
using fan beam dual energy x-ray absorptiometry with Hologic QDR-4500W densitometers 
(Hologic, Inc., Waltham, MA). Standard procedures for subjects positioning and scan analysis 
were executed for all scans. All measurements were performed on the right hip unless a 
subject reported a right hip replacement or metal objects in the right leg. The coefficient of 
variation in our laboratory is 0.9% and 0.7% at the lumbar spine and the total hip respectively 
(Lau et al., 1996). 
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Statistical analysis 
All analysis was performed using SPSS version 15.0 software (SPSS Inc., Chicago, 
USA). The relationships between age and bone parameters were demonstrated by scatter plots 
function. In all cases of women, a two-segment model were plotted which allow different 
slopes before and after 50 years of age yielding the best fit. Differences in changes over age 
between men and women were tested using a linear regression model. The comparison of 
differences between radius and tibia was assessed using a repeated measure to compare 
regression coefficient in a regression model (Kroger et al.，1999; Compare regression 
coefficients). 
For the second part of the study, the relationship between determinants and BMD was 
assessed by linear regression. For most of the risk factors, units of change were chosen to be 
approximately 1 standard deviation in the distribution of a given variable, with age and 
weight adjustment. Variables which were found to be significantly associated (p-value<0.05) 
with BMD were then entered into a multiple regression model. 
For the performance of pQCT and DXA on fracture discrimination, demographic data 
were presented as mean and standard deviations and compared between groups by linear 
regression. The ability of each device and variable to discriminate between fracture and 
non-fracture groups was determined by receiver operator characteristics (ROC) analysis. Data 
were presented as the area under the curve (AUC) with 95% confidence intervals. A 
significance level of p-value<0.05 was used for all analysis. 
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CHAPTER 4 
RESULTS 
(a)Relationships between age, bone density and geometry 
Table 1 summarized the anthropometric data in 662 Hong Kong Chinese men and 
women. Height, weight and BMI were different among each age group in both men and 
women. Height and weight declined with increasing age in both sex and men were taller and 
heavier than women in each age group. 
For men and women, aging was associated with declining total, trabecular and cortical 
bone mineral density in upper and lower limbs (Table 2 and 3). 
In men, the trabecular and cortical bone density went into a decline steadily. The decline 
in trabecular bone density was steeper than that of cortical bone density in both radius and 
tibia. In old women, trabecular bone mineral density was lower than that of men. 
However, average cortical bone density of upper and lower limbs was higher in women 
in a few age groups, 20-29 years, 30-39 years and 40-49 years, and became higher in men 
thereafter. It was remarkable that in women the cortical bone density of the extremities 
declined sharply from 50 years (slope at radius = -3.57, slope at tibia = -2.69). 
Table 4 reported the slope of age-related changes in bone parameters of men in general 
and women (before and after the age of 50 years). This age threshold was selected because it 
yielded the best fit and the age of natural menopause usually occurred around 50 years 
(Hormone supplement therapy, 2006; U.S. Department of Health and Human Services, 2001), 
although the age of menopause was not asked in the examination. 
The age-related changes for the pQCT measurements at the two measuring sites were 
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shown in Figs. 3-12. For the relationship between age and trabecular bone density, neither 
prominent deviation from linearity nor region-specific difference was observed (Fig. 6). 
However, the situation was totally different in total bone and cortical bone, especially in 
women. In addition, the age-related declining of bone density at radius was statistically 
steeper than that of tibia in men in general and women at older ages (Table 4). 
There were large decreases in trabecular vBMD before midlife and continued throughout 
life. The decrement seemed to begin before middle life in women (slope at radius before age 
50 years = -0.64; slope at tibia before age 50 years=-0.75) and was greater in women aged 
after 50 years than that of men at both sites. 
The size of trabecular bone at the two sites also began to increase before middle age and 
continued throughout life (Fig. 8). The expansion in trabecular bone reflected endosteal 
resorption of cortical bone with aging. On average, tibia underwent slightly more 
endocortical bone resorption with aging in either sex. 
However, the extent of periosteal apposition seemed to be less than that for endosteal 
resorption (Fig. 5). As a consequence, the size of cortical area decreased slightly with aging at 
both sites but statistically steeper at tibia (Fig. 11). 
Similarly, cortical vBMD decreased with aging at both the radius and tibia. Nonetheless 
the decrease was relatively reserved in men; there was steady increase in vBMD at both sites 
until midlife in women. Thereafter, there was a sharp decrease, and the vBMD of the two 
sites dropped linearly and to a similar degree, although radius is non-weight-bearing and tibia 
is weight-bearing. The role of menopause and deficiency of estrogen may induce this loss and 
offset the difference in mechanical effect on the measuring sites. 
The minimum moment of inertia, which provides an estimate of the minimal resistance 
to bending of the examined section (Ruff and Hayes, 1982), shared similar trends with those 
observed for cortical bone area. The changes in minimum moment of inertia were 
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considerably different between two sites. At tibia, the decline in moment of inertia was 
steeper than that of radius, especially in men (slope at tibia=-42.81). On the contrary, we 
observed the average values were relatively stable with ages at radius in men (slope at 
radius=-0.82) (Fig. 12). 
(b) Risk factors of vBMD in peripheral sites 
The characteristics of the subjects studied were shown in Table 5. Subjects' age ranged 
from 65 to 98 years (Fig. 13). Age and weight adjusted regression coefficients between 
various factors and BMD at the radius and tibia for both sexes were shown in Tables 6 and 7. 
Lifestyle factors 
Aging was associated with lower BMD at all sites in both sexes, while body weight was 
positively associated with trabecular BMD at all sites in men and at tibia in women. Since 
age and weight were consistently related to bone density, the relationships between other 
variables and BMD were examined after age and weight adjustment. 
After age and weight were considered, body height was positively associated with 
cortical BMD at radius in both sexes, but negatively associated with trabecular BMD at tibia 
in men. While whole body fat percentage was positively associated with trabecular BMD at 
tibia in women. On the other hand, no association was observed between alcohol intake, 
cigarette smoking and BMD in both sexes. Grip strength showed positive effect on cortical 
BMD at radius in women, whereas walking speed was weakly associated with BMD at 
extremities; however, these changes became insignificant by adjusting for age and weight 
(Tables 6 and 7). 
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Medical history and medications 
A history of gastrectomy or bowel resection was associated with lower trabecular BMD 
at all sites in men (Table 6). In men, subjects with a history of diabetes mellitus had higher 
trabecular BMD at both sites, while diabetes subjects had higher cortical BMD at tibia in 
women. A history of hypertension was positively associated with BMD at tibia in women 
(Table 7). 
The use of alpha-blocker, angiotensin converting enzyme inhibitor (ACE inhibitor) and 
hypoglycemic agents were positively associated with trabecular BMD at all sites in men. For 
women, the use of diuretic thiazide was positively associated with cortical BMD at both sites, 
while subjects on nitrate had higher BMD at radius. The use of hypoglycemic agents had 
higher trabecular BMD for men and cortical BMD at tibia for women. Subjects on inhaled or 
oral corticosteroid had reduced cortical BMD at radius and tibia in women and men 
respectively (Tables 6 and 7). 
Fracture history 
A history of fracture after age 50 years was present in 8.6 % and 16.4% of men and 
women respectively, was associated with lower BMD at all measurement sites in women and 
lower trabecular BMD at both sites in men (Tables 6 and 7). 
Multivariate model 
Factors associated with BMD in multivariate analysis were shown in Table 8. On 
multivariate analysis of men, body weight and intake of alpha blocker were associated with 
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higher trabecular BMD at all sites, while height had higher cortical BMD at radius. History of 
diabetes mellitus was positively associated with trabecular BMD at radius, while the use of 
ACE inhibitor and hypoglycemic agents were positively associated with trabecular BMD at 
tibia. For women, body weight and whole body percentage fat had higher trabecular BMD at 
tibia, while height and intake of diuretic thiazide had higher cortical BMD at radius. Intake of 
nitrate and history of hypertension had higher BMD at radius and tibia respectively. 
For men, age, history of gastrectomy or bowel resection and fracture after age 50 years 
had lower trabecular BMD at both sites, while body height was negatively associated with 
trabecular BMD at tibia. Intake of inhaled or oral corticosteroid had lower cortical BMD at 
tibia. In women, age and a history of fracture after age 50 years had lower BMD at all sites. 
(c)Performance of pQCT and DXA on fracture discrimination 
356 population-based elderly men and 313 postmenopausal women were included in this 
part of the study. The densitometry data of the 13 men and 18 women who suffered fractures 
during the course of the study and of the rest and of the 343 men and 296 women who did not 
were shown in Table 10. Total number of fractures, according to site and incidence by sex, 
were shown in Table 9. The most common fracture was wrist. It seemed that subjects with 
fracture were older and lighter than those who did not. 
During an average 4 years follow up, 13 men and 18 women suffered non-traumatic 
fracture. We examined the ability of different devices to discriminate between fracture and 
non-fracture groups using receiver operating characteristic curves analysis. Area under a 
ROC curve for each device was shown in Table 11. pQCT and DXA measurements at all of 
the sites have insignificant AUC except for radial trabecular bone measurement in women. 
Neither pQCT nor DXA measurements were able to discriminate between subjects with and 
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without incident fracture in both sexes, though, radial trabecular bone measurement in 
women shown a significant AUC of 0.649 (Table 11). 
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CHAPTER 5 
DISCUSSION 
In recent years, many studies have been concentrated on the relationship between bone 
structure, geometry and bone density. The introduction of pQCT provides the opportunity to 
investigate bone structures as well as bone geometry where cortical bone is well represented 
and to assess trabecular and cortical bone separately. Several studies focused on the changes 
in bone density at radius between two sexes (Russo et al., 2003; Jasegawa et al., 1997). Some 
of them studied the risk factors of decline in bone density at tibia (Lai et al., 2006). Despite 
the above research works, little is known about the change of bone density and geometry at 
both radius and tibia from early adulthood to the elderly in the Chinese population. 
Relationships between age, bone density and geometry 
The present study was the first to report on regional differences in bone density and 
geometric distribution of the trabecular and cortical bone at radius and tibia in the Chinese 
reference population using pQCT for both genders. Our major findings indicated that there 
was a substantial difference in bone density and geometric distribution between different 
measuring sites of the two sexes. We found that young women have a generally smaller 
cross-sectional bone area and bone density in the extremities, compared with those in men 
(Tables 2 and 3). Smaller bones are less strong than larger bones, even when there is an 
equivalent bone density. However，smaller bones may be appropriate for their shorter and 
lighter body size of young women who have lesser skeletal loading (Table 1). Nevertheless, 
the decreased bone size may prone elderly women to a greater fracture risk than elderly men 
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after considerable age-related bone loss has occurred (Riggs et al., 2004). 
Trabecular bone density declined steadily with age at radius and tibia after reaching peak 
bone mass in both sexes (Fig. 6). The decrease in trabecular vBMD was caused mainly by 
thinning of trabeculae in men and mainly by loss of connectivity in women (Aaron et al., 
1987). The amount of trabecular bone lost during aging in women and men was similar, yet 
Seeman pointed out that bone loss proceeds more slowly in men because of the reduced bone 
formation rather than increased resorption (Seeman et al., 2006). However, the decline in 
trabecular vBMD started in early adulthood in both sexes suggesting that the age-associated 
reduction in trabecular bone density was not due solely to changes in circulating hormones 
but also responsive to physical activity (Russo et al., 2003). Without relying on excessive 
hormones to survive, trabecular bone density started to decline in early adulthood and 
continued to drop steadily even after menopause. 
The progressive enlargement of trabecular area obtained in both sexes at the two sites 
was at the expense of the cortical area, which indicated a process of cortical trabecularization 
(Fig. 8). On average, tibia underwent slightly more corticoendosteal resorption of bone with 
aging than radius. This may attribute to the effect of mechanical stresses on lower limbs 
which stimulates trabecularization. In trabecularization, bone mass decreased resulting in the 
decrease in bone strength. To compensate for the diminished bone density, periosteal 
apposition took place at both sites in both sexes (Fig. 5). However, the finding that cortical 
area decreased slightly with ages indicated that the gain in cortical bone by periosteal 
apposition cannot completely offset the adverse effect of cortical bone loss in endosteal 
resorption (Fig. 11). The rate of periosteal apposition may be limited by the deficiency of 
androgen. Seeman et al. (2006) also suggested that estrogen have a biphasic, dose-dependent 
effect, stimulating at low levels, inhibiting at higher doses and that a threshold level of 
bioavailable estrogen was needed for the regulation of male skeleton (Khosla et al., 2002). 
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Nevertheless, men had greater cortical area than women and it showed only little decrease 
with age at radius and tibia; whilst a relatively large net loss of cortical area observed in 
women at both sites as a consequence of the rate of endocortical resorption over periosteal 
apposition. In fact, the expansion of total bone area in women indicates the reduction in 
estrogen levels after menopause may result not only in the loss of bone mineral density, but 
also an increase in periosteal apposition, since estrogen is known to inhibit periosteal bone 
formation, on the basis of data from experiments in rats (Turner et al., 1987). Women also 
showed a decline in moment of inertia at all sites with aging while it remained relatively 
stable across age in upper limbs of men (Fig. 12). However, there was a different aging 
pattern for radius and tibia; the increment of total and trabecular area of radius exhibited a 
parallel pattern whereas the analysis performed at tibia did not. As a result, radius showed 
little change in cortical area and somewhat constant in moment of inertia with age, while tibia 
showed a little decrease in both cortical area and moment of inertia. 
The changes in cortical density and geometry also proceed in a different way at the two 
sites between sexes. In men, the amount of cortical bone loss at radius was less than women 
did (Fig. 9). In addition, men have a substantially larger cross-sectional bone area and bone 
density which provides a better mechanical support. Therefore, cortical bone density declined 
slightly over the entire lifespan, especially at tibia. In women, we found that the amount of 
cortical bone remained substantially stable before the age of 50 years and became drastically 
lower thereafter (Table 4). The finding of higher cortical bone density in younger women than 
men suggested that gender difference in bone density in Chinese adolescents exists, which 
was similar to those of other ethnic groups studied (Faulkner et al., 1996; Neu et al., 2001; 
Zanchetta et al., 1995). The main reason for these apparent differences may be attributed to 
gender-related differences in activity of daily living as well as changes in height and weight 
(Wu et al., 2005). In fact, boys are physically more active than girls, resulting in more 
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micro-fractures and hence lower cortical bone density. Comparing cortical bone density 
between radius and tibia (Fig. 9), the decline in cortical bone density at radius was steeper 
than that of tibia for both men and women. A sharp decline was observed in radial cortical 
density starting from aged 50 in women, whilst the bone density was relatively stable with 
age at tibia, especially in men. It is of interest, in women at older ages, that the slope of the 
declining cortical bone density at radius was steeper than that of tibia, which is 
weight-bearing, indicating that the effect of mechanical stresses may dominant over the effect 
of estrogen deficiency (Table 4). 
The results indicated that while both men and women underwent age-related geometric 
remodeling of the extremities, bone strength reserved better in men than women. Although 
both sexes showed about the same degree of periosteal apposition, parallel changes occurring 
in men keeping cortical area to remain relatively constant while women did not. Furthermore, 
bone density, torsional and bending strength and rigidity were relatively stable in men 
because of the outward redistribution of bone tissue (Jiang et al.，1999; Burr and Martin, 
1983), while women declined sharply in these properties with age. 
Thus, the age changes in bone geometry appeared to counteract, or compensate for, age 
reductions in material strength in men, while in women they did not. It has been shown that 
the trabecular and cortical bone density declined more with aging in women than men, this 
difference between two sexes and sites may partly explain the higher incidence of fractures 
among women in the elderly (Buhr and Cooke, 1959; Lips, 1997). 
Risk factors of vBMD in peripheral sites 
Whilst some studies have examined the determinants of bone health in elderly men with 
DXA, few have specifically included both men and women, measured bone density at upper 
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and lower extremities with pQCT (Uusi-Rasi et al., 2002). The current study is of clinical 
importance to evaluate the relationship between a host of physical and lifestyle factors with 
trabeulcar and cortical BMD in the Chinese elderly. It provides more information on the 
determinants of BMD at the extremities with pQCT. In this population, a history of fracture 
since age 50 years was found to be strongly associated with lower BMD in both sexes. In 
women, this relationship was significantly shown at all sites. This concurs with the notion 
that Caucasian men with previous fracture have lower BMD (Orwoll et al., 2000). In fact, 
previous fracture is an important predictor for future fracture because as Orwoll points out 
that a history of fracture was shown linking to higher risk of future fracture (Orwoll et al., 
2000). Therefore, the relationship between previous fracture and low BMD should be of 
considerable clinical values in future fracture and needed further study. Age has been well 
known to have negative effect on BMD in both sexes, especially in women, a finding 
consistent with our observations in the previous part in which loss of trabecular and cortical 
bone occurred across ages in both sexes. 
Body weight has shown positive association with trabecular BMD in men and women. 
This finding was consistent with reports in women (Orwoll et al., 1996; Qin et al., 2002) and 
other studies in men (Cauley et al., 2005). Increased body weight appeared to preserve bone 
integrity, which may be related to increased mechanical forces on the bones (Douchi et al., 
2000; Ribot et al., 1994). Trabecular-rich at weight-bearing regions were more benefit from 
mechanical loading, which was consistent to our findings that stronger association with BMD 
was observed at tibia. Taller men and women had higher cortical BMD at radius. However, 
taller men had lower trabecular BMD at tibia. The lower BMD at lower limb among taller 
men was consistent with the observation that taller men have lower BMD and increased risk 
of hip fracture (Hemenway et al., 1995). 
There were some medical factors found to be important determinants of BMD of men or 
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women. Gastrectomy or bowel resection was related to low trabecular BMD at all sites in 
men. This association has been reported in previous findings (Orwoll et al., 2000). The 
removal of part or all of digestive system may reduce the absorption of some nutrition, such 
as calcium and vitamin D, resulting in lower BMD. Similarly, the use of inhaled or oral 
corticosteroid had lower cortical BMD at tibia in men, and remained a significant determinant 
of BMD in multivariate models. This observation seemed to contradict to previous finding, 
whereby the use of corticosteroid has no significant effect on cortical bone (Ruegsegger et al., 
1983). However, recent studies have documented that systemic glucocorticoids 
administration decreased both cortical bone density and cortical bone volume (Tsugeno et al., 
2001). Our findings of higher trabecular BMD observed in men and women with diabetes 
mellitus and hypertension respectively were consistent with previous observations of the 
impact of diabetes mellitus and hypertension on bone density in other skeletal sites (Lau et al., 
2006; Cauley et al., 2005). The greater trabecular BMD among men with diabetes mellitus 
was independent of body weight and could reflect other biological mechanisms. In fact 
greater abdominal obesity, insulin and growth factors could contribute to higher BMD among 
the diabetics (Barrett-Connor and Kritz-Silverstein, 1996). This agreed with the current 
findings that hypoglycemic agents use have positive effect on bone density at tibia. 
Hypertension has been associated with abnormalities in calcium metabolism, leading to 
increased calcium loss, and resulting in lower BMD (Cappuccio et aL, 1999). However, the 
positive association between hypertension and BMD may result from confounding by the use 
of medications that may increase BMD. Several cardiac drugs, including ACE inhibitor, 
thiazide diuretics, alpha-blocker and nitrate were associated with higher BMD. Although few 
studies analyzed the effects of ACE inhibitors on BMD, it has been reported that ACE 
inhibitor has a beneficial effect on the skeleton (Perez-Castrillon et al., 2003). ACE inhibitor 
acts by blocking angiotensin II synthesis, lowering the angiotensin concentration and thus 
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inhibiting bone resorption and promoting mineralization. Similarly, several studies proved 
that hypertensive subjects treated with thiazides presented a higher BMD, mainly cortical 
bone (LaCroix et al., 2000; Bolland et al., 2007) and fewer fractures (Caulety et al., 1993; 
Feskanich et al., 1997; LaCroix et al., 1991). Thiazides could act directly on the cells 
participating in bone turnover or indirectly by decreasing the renal excretion of calcium and 
achieving a positive balance of such excretion. However, the mechanism of alpha-blocker in 
elevating BMD is still unclear. Nitrate has been reported to prevent postmenopausal 
osteoporosis in elder women by decreasing bone resorption and increasing bone formation 
(Jamal et al., 2004). 
In multivariate models, we found no relationship between BMD and a number of factors 
commonly associated with skeletal health. Alcohol intake has been linked to higher BMD in 
some studies (Orwoll et al., 2000), but there was no relationship in the current study. Possibly 
this reflected the low statistical power to detect an association because of the low prevalence 
of consumption. 
Whereas other reports have suggested an effect of physical activity on BMD in older 
men (Orwoll, et al., 2000; Glynn et al., 1995)，our finding of physical activity level was 
unrelated to BMD, it may be due to ascertainment difficulty. Lau et al (2006) and Orwoll et al. 
(2000) also reported associations between lower BMD and smoking, while in the current 
study, cigarette smoking relationships were not apparent at any measurement site in the 
multivariate models. 
Performance ofpQCT and DXA on fracture discrimination 
To our knowledge, bone strength is strongly correlated with BMD, and many studies 
demonstrated that BMD measurements predict fracture risk (Melton et al., 1997). In fact, 
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subjects with at least one previous fracture are at higher risk than those without a previous 
fracture, yet risk in subjects with or without previous fracture increases as a result of the 
reduction in BMD (Kroger et al., 1999). Therefore, it is of utmost importance to seek a bone 
densitometry technique which can provide crucial information for clinicians in assessing the 
risk of incident fracture in an accurate and convenient way. 
For many years, lots of studies have been focused on the comparison of the sensitivity 
between pQCT and DXA. Although fracture prediction by judging BMD status has been 
reported to be site-dependent (Cummings et al., 1993) and many of them showed that BMD 
assessment at the radius and the tibia has less discriminative power than that of measurements 
at the hip (Augat et a l , 1998). In addition, pQCT has been reported to have poorer ability in 
discriminating fractures from non-fractures and less sensitive than measurements using DXA 
(Formica et al., 1998; Boonen et al, 1997). Yet, we found that pQCT was slightly better than 
DXA in predicting fracture in older women, though no firm conclusion can be made because 
of the limited number of fractures (Table 11). In fact, many reports have shown that fractures 
at all skeletal sites such as proximal femur and spine correlated well with low bone mass at 
the distal forearm (Fujii et al., 1996; Schneider et al., 1988). This implied that there was no 
substantial difference in sensitivity between axial and peripheral BMD measurements for 
subjects with generalized osteoporosis. In that, pQCT provides exclusive information 
concerning bone geometry with low radiation dose whereas DXA can only measures bone 
density in two dimensions. With the ability to quantify trabecular and cortical BMD 
separately at an easily accessible appendicular site, pQCT seems to be an ideal method of 
assessing bone density changes and fracture prediction. 
Concerning the precision of pQCT, many studies have been worked on this issue (Augat 
et al., 1998; Nijs et al., 1998). It was found that the reproducibility of the machine was most 
affected by the positioning. Positioning may have a dramatic impact on precision errors of 
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measurement variables (Takada et al., 1996)，especially in scanners using single slice 
technique. However, this problem has been solved in newer versions of pQCT using single 
slice or even multiple slices technique by placing a reference line to assure the same region of 
interest was being scanned in the subsequent measurements. 
Although we found most of the sites measured by peripheral QCT and DXA limited 
predictive power for incident fracture; we failed to show the association between central or 
peripheral devices and specific fracture site as the sample size for fracture cases was not in 
large number in the current study. Hence, further study on site-specificity of densitometry 
measurement is needed. 
In fact, previous studies have shown that the hip fracture incidence in Asian countries 
was much lower than in Europe and North America in which both genetic and environmental 
factors may contribute to such variations (Lau et al., 2001). This phenomenon may attribute 
to the low incidence of falls in community-based older populations of Hong Kong compared 
to that in UK, US and Europe (Ho et al., 1996) and Lau and Woo (1998) found that falls in 
the elderly were an independent and important determinant of hip fracture. The low incidence 
of fall may be due to recall bias in retrospective study, especially among those elderly 
subjects who tended to have poor memory (Cummings et al., 1988)，yet different lifestyle and 
living environment among racial may contribute to such variations. Hong Kong is a highly 
urbanized community and most of the population resided in government-provided low-cost 
high-rise housing consisting of small floor areas. In addition, the mild climate and low level 
of activity accounted for the low incidence of fall. Moreover, the use of psychotropic drugs, 
sleeping pills and heavy drinking were found to be the risk factors for falls in Western elderly 
population (Ho et al., 1996), whilst the prevalence of taking these medications and heavy 
drinkers in our population was relatively low, resulting in the low incidence of falls in the 
Chinese elder subjects. 
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Limitations of the study 
The current study was one of the few studies to describe the age-related changes in bone 
density and bone geometry, as well as determinants of bone loss in the Chinese elderly with 
pQCT. Nevertheless, our study had several limitations. The most obvious one was selection 
bias. Subjects recruited were not population based as we examined elders that were able to 
walk independently whose characteristics may differ from the general population. Moreover, 
a substantial proportion of the subjects of our study did not return for follow-up measurement. 
Subjects who did not return were mostly frail and elderly and most likely had greater rate of 
bone loss and higher incident fracture rate than those who did. Therefore, our estimates of 
fracture rate may be conservative estimates of the true value. Despite these concerns, as in all 
other cross-sectional studies, there existed the inherent weaknesses of not being able to 
discriminate the cause-effect relationships of variables. Recall bias was also an important 
limitation, as many of the variables examined were derived from subjects' recall instead of 
from direct ascertainment in the study. Finally, the effect of confounding factors was another 
limitation. The influence of some variables on BMD was difficult to assess due to 
confounding effect and the low prevalence of medications in our population. 
Conclusion 
In conclusion, age-related changes in bone were complex. During aging, trabecular and 
cortical BMD decreased in both sexes and sites. To compensate for its loss and reserve bone 
strength, age-related geometric remodeling took place in both women and men, but more so 
in men, increasing the cross-sectional area of bone by periosteal apposition. 
A number of lifestyle, behavioral characteristics and medical conditions were associated 
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with BMD in this older community-dwelling group of Chinese. Increased weight, a history of 
diabetes mellitus and intake of cardiac drugs, such as alpha-blocker, ACE inhibitor and 
diuretic thiazide were associated with increased bone density; whereas age and previous 
history of fracture were among strongest predictors of reduced bone density. Hypoglycemic 
agents use and nitrate use were associated with increased bone density, whereas gastrectomy 
and use of corticosteroid were associated with decreased bone density. Unlike other studies, 
we found no association between bone mineral density and alcohol use, cigarette smoking 
and physical activity, or parity. 
For the discriminating ability between fractures from non-fracture cases in the elderly, 
only radial trabeucular BMD showed the competence whereas both DXA and pQCT had 
limited predictive power for incident fracture. Yet, volumetric BMD and geometric 
parameters of the trabecular structure and the cortex obtained from cross-sectional image 
have the potential to provide a non-invasive surrogate for conventional bone measurement. 
From a clinical perspective, these results provided information useful for the identification of 
the elders who may be at risk for low BMD and fractures and who deserve further evaluation. 
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Table 1. Demographic data of subjects according to sex and age groups. 
Values are mean 士 SD 
^ Age (years) Height (cm) Weight (kg) BMI (kg/m^) 
Men 
2 0 - 2 9 3 6 2 4 . 3 9 士 3.1 1 7 2 . 4 ± 7 . 1 6 9 . 7 ± 1 0 . 6 2 3 . 5 ± 3 . 1 
30-39 3 9 3 4 . 6 7 士 3.1 171.0 ± 5 . 8 6 5 . 9 士 8.4 2 2 . 5 ± 2 . 5 
4 0 - 4 9 5 0 4 4 . 0 6 士 3.0 1 6 9 . 0 士 4.6 6 9 . 4 士 8.9 2 4 . 3 ± 2 . 9 
5 0 - 5 9 4 5 5 4 . 0 7 士 2.7 1 6 6 . 6 ± 5 . 7 6 7 . 1 ± 8 . 2 2 4 . 2 ± 2.3 
60-69 44 67.55 ± 1.8 164.7 ±5.2 62.0 ±8 .1 22.8 ± 2.6 
7 0 - 7 4 4 4 7 1 . 8 6 士 1.3 1 6 2 . 7 士 5.4 6 1 . 3 士 10.8 2 3 . 1 ± 3 . 6 
75-79 44 76.52 士 1.4 163.2 士 5.9 59.5 士 9.3 22.3 士 3.1 
8 0 + 4 4 8 2 . 9 5 士 3.：3 1 6 1 . 4 士 5.9 5 6 . 5 士 10.4 2 1 . 6 ± 3 . 4 
ANOVA^ p<0.001 p<0.001 p<0.001 p<0.001 
Women 
2 0 - 2 9 4 2 2 5 . 4 8 士 2 . 6 1 6 0 . 4 士 6.0 5 0 . 7 士 5.0 19.7 士 1.8 
3 0 - 3 9 3 9 3 4 . 6 2 士 2 . 9 1 5 7 . 5 ± 5 . 5 4 9 . 6 士 6.5 2 0 . 0 士 2 . 2 
4 0 - 4 9 5 0 4 4 . 7 士 3.2 1 5 6 . 6 士 5.2 5 4 . 9 士 8.6 2 2 . 4 士 3.0 
5 0 - 5 9 5 0 5 4 . 5 6 士 2 . 9 1 5 4 . 0 ± 5 . 1 5 3 . 2 士 6.5 2 2 . 4 士 2 . 2 
6 0 - 6 9 5 0 6 5 . 7 6 士 2.8 1 5 3 . 2 士 5.4 5 4 . 8 士 6.1 2 3 . 4 士 2.6 
7 0 - 7 4 3 7 7 1 . 8 4 士 1.4 1 5 1 . 2 士 4.9 5 3 . 4 士 6.1 2 3 . 4 士 2 . 9 
7 5 - 7 9 2 5 7 6 . 9 2 士 1 . 6 1 4 9 . 8 士 4.7 5 3 . 4 士 9 . 0 2 3 . 8 士 3.7 
8 0 + 2 3 8 3 . 5 2 士 3.2 1 4 8 . 6 士 4 . 4 4 6 . 8 士 7.0 2 1 . 2 士 2.6 
ANOVA 乡 p<0.001 p<0.001 p<0.001 p<0.001 
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Table 5. Characteristics of subject studying risk factors of v B M D (mean 士 SD). 
Men W o m e n p_vahic 
Number 428 424 
Age (years) 73.1(5) 74.2(6.1) 0.003 
Weight (kg) 61.6(9.0) 53.1(8.3) <0.0001 
Height (cm) 163.1 (5.7) 150.3(5.3) 0.132 
Bone mineral density (g/cm^) 
Radius Trabecular B M D 183.4 (31.9) 147.4 (39.8) 0.98 
Radius Cortical B M D 1159.5 (87.0) 1127.9 (39.5) 0.617 
Tibia Trabecular B M D 203.6 (27.4) 177.8(33.1) <0.0001 
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Table 8. Multivariate model of risk factors for B M D of men and women adjusted with age 
and weight. 
easurement site Variable Partial Probability 
^ level 
Men 
Radius 4% Trabecular Diabetes (+) 0.137 0.005 
(total r2=0.097) Age (-) -0.121 0.013 
Alpha-blocker (+) 0.125 0.010 
Surgery to remove all or part of stomach or -0.113 0.020 
intestines (-) 
A history of fracture after 50 years (-) -0.110 0.023 
Weight (+) 0.109 0.024 
Radius 33% Cortical Height (+) 0.155 0.033 
(total r2=0.026) 
Tibia 4% Trabecular Weight (+) 0.250 <0.001 
(total R2=0.158) Height (-) -0.188 <0.001 
Alpha-blocker (+) 0.159 0.001 
Hypoglycemic agents (+) 0.088 0.070 
Surgery to remove all or part of stomach or -0.117 0.016 
intestines (-) 
A history of fracture after 50 years (-) -0.099 0.043 
ACE Inhibitor (+) 0.108 0.026 
Age (-) -0.103 0.035 
Tibia 33% Cortical Corticosteroid (inhaled or oral) (-) -0.160 0.027 
(total R2=0.046) 
Women 
Radius 4% Trabecular A history of fracture after age 50 years (-) -0.143 0.003 
(total r2=0.053) Nitrate (+) 0.136 0.005 
Age (-) -0.129 0.008 
Radius 33% Cortical Age (-) -0.263 <0.001 
(total r2=0. 152) Diuretic, thiazide (+) 0.137 0.005 
Nitrate (+) 0.135 0.005 
Height (+) 0.124 0.010 
A history of fracture after 50 years (-) -0.124 0.011 
Tibia 4% Trabecular Weight (+) 0.120 0.014 
(total r2=0. 168) A history of fracture after 50 years (-) -0.189 <0.001 
Age (-) -0.142 0.004 
Hypertension (+) 0.121 0.013 
Whole body percentage fat (+) 0.110 0.024 
Tibia 33% Cortical Age (-) -0.207 <0.001 
(total r2=0. 100) Hypertension (+) 0.146 0.003 
Hypoglycemic agents (+) 0.139 0.004 
A history of fracture after age 50 years (-) -0.117 0.016 
The Use of pQCT 10 
Table 9. Total fracture incidence by sex and type. 
Site Male Female Total 
Skull 2 0 2 
Upper limb 
Arm 2 0 2 
Shoulder 0 0 0 
Wrist 5 6 12 
Hand/ finger 1 1 2 
Ribs 0 2 2 
Vertebral 
Cervical vertebral 0 0 0 
Thoracic vertebral 0 0 0 
Lumbar vertebral 0 3 3 
Pelvis 0 0 0 
Lower limb 
Leg 1 0 1 
Hip 2 2 4 
Foot/ ankle/ toe 0 4 4 
Total \3 18 M 
The Use of pQCT 10 
Table 10. Densitometry data (mean士 SD) of subjects with & without incident fracture. The 
differences between non-fracture and fracture subjects for all the variables were 
compared by linear regression; *p<0‘05’ **p<0.01 are shown. 
Variable Non-fracture group Fracture group (Any fracture) p-value 
Number of subjects Mean士SD Number of subjects Mean士SD 
Men 
Age 343 72.6士4.9 13 73.9士 4.1 0.371 
Weight (kg) 343 62.1士8.8 13 62.0士8.4 0.957 
Height (cm) 343 163.1士5.6 13 164.5土6.0 0.409 
DXA 
Total hip B M D 343 0.84士0.11 13 0.85士0.10 0.555 
Femoral neck B M D 343 0.67士0.10 13 0.64士0.05 0.353 
pQCT 
Radius trabecular B M D 343 185.3士31.8 13 173.9士29.4 0.222 
Radius cortical B M D 343 1165.7士35.2 13 1161.1士41.2 0.706 
Tibia trabecular B M D 343 205.2士27.4 13 197.4士27.2 0.331 
Tibia cortical B M D 343 1156.9士30.1 13 1155.5士25.6 0.876 
Women 
Age 295 74.1 士6.1 18 74.7士6.5 0.670 
Weight (kg) 295 53.5士8.3 18 51.9士7.8 0.436 
Height (cm) 295 150.5±5.3 18 151.2士5.3 0.647 
DXA 
Total hip B M D 295 0.70±0.12 18 0.67士0.14 0.370 
Femoral neck B M D 295 0.58±0.10 18 0.55士0.10 0.398 
pQCT 
Radius trabecular B M D 295 150.4士42.3 18 134.3士24.1 0.130 
Radius cortical B M D 295 1131.0±38.3 18 1131.4士40.5 0.849 
Tibia trabecular B M D 295 180.1士31.1 18 166.6士25.2 0.111 
Tibia cortical B M D 295 1129.0士39.8 18 1132.7士36.9 0.572 
The Use of pQCT 10 
Table 11. Area Under Curve (AUC) with 95% confidence intervals for different densitometry 
devices and measurement sites. The ability of different devices to discriminate 
between incident fracture cases and control is shown by A U C and 95% confidence 
intervals for different densitometry devices and measurement sites p<0.05) are 
shown. 
Variable Subjects with incident fracture 
A U C A U C (95%CI) 
Men 
^^ 
Total hip B M D 0.616 (0.498-0.734) 
Femoral neck B M D 0.609 (0.458-0.760) 
pQCT 
Radius trabecular B M D 0.627 (0.471-0.783) 
Radius cortical B M D 0.598 (0.446-0.750) 
Tibia trabecular B M D 0.604 (0.468-0.740) 
Tibia cortical B M D 0.592 (0.451-0.733) 
Women 
DXA 
Total hip B M D 0.570 (0.432-0.709) 
Femoral neck B M D 0.604 (0.474-0.734) 
pQCT 
Radius trabecular B M D 0.649* (0.521-0.777) 
Radius cortical B M D 0.558 (0.421-0.695) 
Tibia trabecular B M D 0.632 (0.521-0.742) 
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The Chinese University of Hong Kong 
The Hong Kong Jockey Club Center for Osteoporosis Care And Control 
The M r O S Study-
Osteoporosis in older men in Hong Kong 
Informed Consent Form 
I declare that I consent to participate in the Mr OS Study - Osteoporosis in older 
men in Hong Kong. The details of the study are as described in the enclosed 
information sheet. The procedures have been clearly explained to me and I understand 
my undertaking. 
I declare that:-
i. I have been made fully aware of the details of the study including its aims, 
methods and use of data. 
ii. I understand that all data collected will be used for research purposes only, and 
will be kept strictly confidential by the researchers. Study subjects will not be 
identified by name. 
iii. I volunteer for the study and I can choose to quit the study at any time. 
iv. I acknowledge that I understand the contents of this consent form. 
Name of Participant Signature of Participant 
Name of Witness Signature of Witness 
Date 
Appendix D 85 
The Chinese University of Hong Kong 
The Hong Kong Jockey Club Center for Osteoporosis Care And Control 
The M r O S Study-
Osteoporosis in older men in Hong Kong 
Participant information sheet 
1. You are invited to participate in Mr OS Study - Osteoporosis in older men in 
Hong Kong. 
2. The study will last for 4 years and will involve the following at the baseline, 24 
months and 48 months clinic visit: 
a) Interview on your lifestyle by a research nurse 
b) The following measurements will be performed. 
1. Height and weight 
2. Visual acuity, contrast sensitivity and depth perception 
3. Grip strength, and coordination 
4. Pulse and blood pressure 
5. Bone density at spine and hip by Dual Energy X-ray Absorptiometry 
and ultrasound 
6. X-ray spine 
7. 20 ml of fasting blood and overnight urine will be collected. D N A will 
be extracted and studied. 
3. All personal information will be kept strictly confidential and will be used only 
for research purposes. 
4. You can choose to exit the study at any time. 
5. If you have any questions about the study, concerns or about what to do if you 
have problems during the study, you may contact Miss Chan or Miss Lee during 
office hours at telephone 22528826/ 22528858. 
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香港中文大學賽馬會骨質疏鬆預防及治療中心 ^ ^ 
The Chinese University of Hong Kong ^ f l^Mk 
Jockey Club Centre for Osteoporosis Care and Control K ^ m S 
「致力促進全民骨路健康及改善骨質疏鬆症患者生活素質」 ^^ijiil^ 
"Towards healthier bone for all and improved quality of life for osteoporosis sufferers " ^^^^ 








病人姓名 出生日期—_/_ — / 
曰 月 年 
病人身分證號碼 
病人簽署 簽署曰期—_/__ / 




香港新界沙田威爾斯親王躲院赛馬會公共衛生學院三樓 電話Tel: (852) 2252 8833 
、 ！ 3 / F , Jockey Club School of Public Health, Prince of Wales Hospital, Shatin, N.T., H.K. 傳真 Fax: (852) 2649 2447 
� 
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香港中文大學 
The Chinese University of Hong Kong 
香港耆英骨質顧跟進計劃 





*Please insert Label* 
Serial Number: 
Name: 姓名： 
D O B : Sex/Age: 
V J 




〇 有 個情況而要蹄西醫？ 〇 有 
甲狀腺素過高，格雷夫斯〇有一"•如果有，你而家有有因爲呢•有 
氏病 (突眼性甲狀腺病 )或〇有 個情況而要腺西醫？ 〇 有 
者有過度活躍概甲狀腺？ 
甲狀腺素過低或者甲狀腺〇有一；如果有，你而家有有因爲呢〇有 
唔夠活躍？ 〇 有 個情況而要蹄西醫？ 〇 有 
骨質疏鬆症，有時叫脆骨〇有一"•如果有，你而家有行因爲呢〇有 
症 ? 〇 有 個情況而要蹄西醫？ 〇 冇 
中風，腦積血或者腦出 〇有一"•如果有，你而家有有因爲呢〇有 
M 〇 有 個情況而要蹄西醫？ 〇 有 
柏金遜病？ 〇有 ~•如果有，你而家有冇因爲呢〇有 
〇 有 個情況而要蹄西醫？ 〇 有 
高血壓？ •有 ~•如果有，你而家有 t r因爲呢〇有 
〇 有 個情況而要蹄西醫？ 〇 冇 
心臟病發，冠狀動脈或者〇有 ~•如果有，你而家有冇因爲呢〇有 
心肌栓塞？ 〇 有 個情況而要蹄西醫？ 〇 冇 
心絞痛(心翳)？ 〇有 ~•如果有，你而家有行因爲呢〇有 
〇 有 個情況而要蹄西醫？ 〇 冇 
充血性心臟衰竭或者心臟〇有 ^•如果有，你而家有有因爲呢〇有 
發大？ 〇 有 個情況而要蹄西醫？ 〇 冇 
慢性阻塞性肺病，慢性支〇有 ~•如果有，你而家有有因爲呢〇有 
氣管炎，哮喘或者肺氣 〇 有 個情況而要蹄西醫？ 〇 有 
m 
前 列 腺 發 炎 或 者 受 到 感 〇 有 • 如 果 有 ， 你 而 家 有 有 因 爲 呢 〇 有 
染 ? 〇 有 個情況而要蹄西醫？ 〇 冇 
青光眼？ 〇 有 • 如 果 有 ， 你 而 家 有 有 因 爲 呢 〇 有 
〇 有 個情況而要蹄西醫？ 〇 有 
白內障？ 〇有一-•如果有，你而家有有因爲呢〇有 
〇 有 I個情況而要蹄西醫？ 〇 有 
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病歷 
2.你從來有有做過胃部或者腸部概切除手術(包括整個或者部份切除手術)？ 
〇 有 〇 有 
1 r 
你喻幾多歲概時候做呢個手術？ I I I 歲 
3.有有西醫或者其他醫護人員話你患有關節炎或者痛風症？ 








〇 髖 • 背 脊 〇 腳 
• 膝 蓋 〇 頸 〇腳板/腳指 
〇手/手指 〇膊頭 〇其他 
〇 手 腕 〇 手 
你有有因爲你嚼關節炎或者關節痛而要食薛？ 
• 有 〇 有 
4.有有西醫或者其他醫護人員曾經話你患有腎石？ 
〇 有 〇 有 
^ 
縣過去五年’你試過幾多次排出賢石或者因爲-石做成陣痛？ [ _ ] _」次 
你而家有tr因爲你概賢石而接受治療？ 
〇 有 • 有 
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病歷 
5.有有西醫或者其他醫護人員話你患有癌症？ 




I 最 初 証 實 診 斷 概 時 候 你 幾 多 歲 ？ 最初証實診斷概時候你幾多歲？ 
l__l_J 歲 歲 
你曾經接受邊一類概治療？(揀所有適合概答案） 
〇放射性治療 〇冇接受任何治療 
〇前列腺切除手術 〇 其 他 
〇睪九切除手術 
〇服食荷爾蒙韵/注射荷爾蒙 
0皮膚癌(唔係黑素瘤） cp肺癌 cp其他類別概癌症 
j ^ • 
I 最 初 証 實 診 斷 概 時 候 最初証實診斷槪時候請註明你係邊一類概癌症： 
你幾多歲? 你幾多歲？ 
最初証實診斷概時候你幾多歲？ 
|_|__1 歲 |__1__| 歲 
I I I 歲 
6.你有時會唔會有頭暈概問題呢？ 
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病歷 
7.職過去12 fi月，你有有跌倒•地下或者跌倒卩旣時候撞倒物件好似枱或者櫈？ 
〇 有 〇 行 
pf系過去12個月，你總共跌倒禍幾冬次？ rR棟一個答塞、 
〇 1 次 
〇 2 至 3 次 
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煙酒用量 
1.你成世人有有食多過一百支(五包)煙？ 
• 有 〇 有 
，r 
你幾多歲開始經常性食煙？ 縣你整段吸煙期間，你平均每日食幾多支煙？ 
| _ J _ I 歲 1 1 1 1 支 
你 家 有 f i " 食 緊 煙 呢 ？ 
〇 有 • 有 
你大槪每日食幾多支煙？ I你_幾多歲停止食煙？ 
1 1 1 1 支 [__|_J 歲 
2.你有有定期性吸食煙斗、雪前或者水煙？ 
〇 有 〇 有 
食腔幾多年？ I你每個星期大槪食幾多斗煙葉？ I你每個星期大槪食幾多支雪節？ 
U U 年 L ^斗 I I I I 支 
3.你成世人有^？飲多過12(罐、杯或者支)含酒精概飲品？ 
Cj)有 〇 行 
，r 
你有有曾經覺得你應該飲少tl的酒？ 
〇 有 〇 行 
你有有曾經試過因爲人馳批評你飲酒而令你覺得好翻？ 
〇 有 〇 有 
你有有曾經覺得飲酒職唔好或者因爲飲酒而感到內疾？ 
〇 有 • 有 
你有fl曾經試過一起身第一件事就係飮酒，藉此嚷鎮定你.神經或者用飲酒嚷趕 
走醉意？ 
〇 有 〇 行 
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酒精用量 
1.縣過去十二個月，你有有最少飲佐任何12(罐、杯或者支)含酒精概飲品？ 
• 有 〇 有 〇拒絕回答 〇唔知 
A.職過去十二個月，你平均每星期、或每月、或每年有幾多日飲含酒精概飲品？ 
〇星期 

















• 有 〇 有 〇拒絕回答 〇唔知 






• 有 （^好少(1至2日） Cp有時(3至4日） （^經常(5至7曰） 
• • • 
，f 
直 去 第 2 題 係 暇 活 動 呢 ？ 
你每日平均會用幾多個鐘頭嚷做呢_坐_度概活動？ 
• 少 過 1 個 鐘 〇 1 至 2 個 鐘 〇 2 至 4 個 鐘 〇 多 過 4 個 鐘 
2.略過去7日，你通常用幾多時間噼屋外行路(唔理爲佐嘅原因)？例如：去玩或者做 
運動、行路返工、帶狗散步、去買餘、掉垃圾、去飲茶、去行街等？ 









0 ^ 9好少 ( 1至 2曰） 9 有 時 至 4 曰 ） 經常(5至7曰） 
+ + + 
，r 
直 去 第 4 題 係 D 的 活 動 呢 ？ _ 
你每日平均會用幾多個鐘頭哦做一_輕量職運動或者消遣概活動？ 




• 有 Cj)好少(1至2日） Cp有時(3至4日） Cj)經常(5至7日） 
，r 去 令 
直去第5題係11的嚼活動呢？ — 
你每日平均會用幾多個鐘頭哦做呢卩的溫和概運動同消閒活動？ 
〇少過 1個鐘 〇 1 至 2 個 鐘 〇 2 至 4 個 鐘 〇 多 過 4 個 鐘 





• 有 Cp好少(1至2日） （^有時(3至4日） C^經常(5至7曰） 
W w w 
直去第6題係卩的t2嚼活動昵？ 
你每日平均會用幾多個鐘頭哦做呢D的劇烈概運動同消閒活動？ 
〇少過 1個鐘 〇 1 至 2 個 鐘 〇 2 至 4 個 鐘 〇 多 過 4 個 鐘 
6.縣過去7日，你用佐幾多時間哦特登做一卩的增強肌肉力量同持久力概運動？例如： 
舉重、掌上壓或者其他類似概活動。 
• 行 （^好少(1至2日） （^有時(3至4日） （^經常(5至7曰） 
W W ^ 
直去第7題係n的titff活動呢？ — 
你每日平均會用幾多個鐘頭哦做一啲增強肌肉力量同持久力概運動？ 
〇少過 1個鐘 〇 1 至 2 個 鐘 〇 2 至 4 個 鐘 〇 多 過 4 個 鐘 
7.略過去7日，你有有做過一D的輕巧概家務，例如：打掃或者洗碗、手洗、萸、琼衫、 
煮飯、買錢？ 〇 有 〇 有 
8. _過去7日，你有有徹過一卩的粗重慨家務或者雜務，例如：吸塵、擦地板、拖地、 
洗窗、洗車、搬傢丨私或者石油氣？ 〇 有 • 冇 
9.職過去7日，你有A•做以下任何概活動？(請答有或者冇） 
A.家居維修，例如：油漆油、貼牆紙、整電器等等 〇 有 〇 有 
B.草地或者庭院工作，例如：剪草、掃樹葉、斬木等 〇 有 • 有 
C.戶外園藝 〇 有 〇 有 
D.照顧其他人，例如：小孩、配偶、或者其他成人 • 有 〇 有 
10.喻過去7曰，你有^^做工(包括有支薪水或係義工)？ 
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體能活動 
1.你有冇每曰或者差不多每日行路當做運動？ 
• 有 〇 有 
，r 
平均嘴講你每日行幾多條街當做運動？（1條街=100米）Mil條 
2.平均哦講你每曰如常附行幾多條街，例如你出去買嚼？ M i l條 
3.喉每日24個鐘頭裏面，你有幾多個鐘瞓低_度？(包括圓度托起隻腳、夜晚圓1丨覺 
或者想瞓覺、休息或者攤嗨個梳化個度腺電視。）每日 ^ ^ 
_ L j小時 
4.喻每曰24個鐘頭裏面，你有幾多個鐘坐_度？(包括坐_度食嘅、揸車或者坐車、 




〇 有 〇 有 
，r 
喉過去一年你有幾多個星期臥床或者坐_張椅度？ L_U星期 
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體能活動 
6. 11(系過去一年你有有晚外邊做義工或者做有薪水支概工作多過一個月？ 




你係唔係行路或者採單車去返工放工概？ c p係 〇唔係 
每日I I I I 分 鐘 
平均工作時間? ^ ^ 
每年I I I個月 每 星 期 • 日 每日[X]小時 
喻一曰柑多個鐘頭，有幾多個鐘頭係坐临度？ LXJ小時係坐略度 
你唔係坐_度個陣時，你做緊以下邊種工作類別？ 
〇 A 〇 B 〇 C 〇所有時間都係坐職度 
工作名稱： 
你係唔係行路或者跌單車去返工放工概？ 係 〇唔係 
，f 
每日I I I I 分 鐘 
平均工作時間? ^ ^ 
每 年 I I I 個 月 每 星 期 • 日 每日 I I I小時 
—曰柑多個鐘頭，有幾多個鐘頭係坐_度？ I I I小時係坐喻度 
你唔係坐喻度個陣時’你做緊以下邊種工作類別？ 
〇 A 〇 B 〇 C 〇所有時間都係坐_度 
A類形 |C類形 
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1.有行醫生曾經話你患有斷骨或者骨折？ 
C p有 〇 有 ~ • 去第2題 
I ，f 
A有有醫生曾經話你患有髖骨斷骨或者骨折？ 
Cj)有 〇冇——• 去第B題 
係邊類嚼醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你職幾多歲概時候患有髖骨斷骨或者骨折？如果你有多過一次概_斷骨或者骨 
折，請列出你每次斷髖骨時槪年齡。 




〇 有 〇行——• 去第C題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你临幾多歲概時候患有手腕或者前臂骨斷骨或者骨折？如果你有多過一次概手腕i 
者前臂骨斷骨或者骨折，請列出你每次斷體骨時概年齡。 
I 歲 I 歲 I 歲 
當時你概手腕或者前臂骨係當時你概手腕或者前臂骨係當時你概手腕或者前臂骨係 
點樣整斷架？ 點樣整斷架？ 點樣整斷架？ 
C有冇醫生曾經話你患有脊椎斷骨或者骨折？ 
C p有 〇 有 ~ • 去第D題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你職幾多歲概時候患有脊椎斷骨或者骨折？如果你有多過一次概脊椎斷骨或者骨 
折，請列出你每次斷髖骨時概年齡。 
歲 歲 歲 
當時你概脊椎係點樣整斷當時你概脊椎係點樣整斷當時你概脊椎係點樣整斷 
I 架 ? ^ 




〇 有 〇有一 " • 去第E題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你临幾多歲概時候患有肩胛或者鎖骨斷骨或者骨折？如果你有多過一次概肩胛或者-
鎖骨斷骨或者骨折，請列出你每次斷髖骨時概年齡。 
歲 歲 歲 
當時你概肩胛或者鎖骨係點當時你概肩胛或者鎖骨係點當時你概肩胛或者鎗骨係點 
樣整斷架？ 樣整斷架？ 樣整斷架？ 
E有有醫生曾經話你患有上臂骨骨斷骨或者骨折; ^ ~ 
〇 有 〇 有 ~ • 去第F題 
，r 
係邊類槪醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你職幾多歲嘲時候患有上臂骨斷骨或者骨折？如果你有多過一次概上臂骨斷骨或者一 
骨折，請列出你每次斷髖骨時概年齡。 
I歲 I歲 I歲 
當時你槪上臂骨係點樣整斷當時你概上臂骨係點樣整斷當時你概上臂骨係點樣整斷 
架? ^ m 
F有有醫生曾經話你患有肋骨或者胸骨斷骨或者骨^ 
• 有 〇 有 ^ • 去第G題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你晚幾多歲概時候患有肋骨或者胸骨斷骨或者骨折？如果你有多過一次槪肋骨或者― 
胸骨斷骨或者骨折，請列出你每次斷髖骨時嚼年齡。 
I歲 I歲 I歲 
當時你概肋骨或者胸骨係點當時你概肋骨或者胸骨係點當時你概肋骨或者胸骨係點 
樣整斷架？ 樣整斷架？ 樣整斷架？ 
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1 • ^^ ^ •••••• 
G有有醫生曾經話你患有大腿骨斷骨或者骨折？ 
• 有 〇有——• 去第H題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你職幾多歲概時候患有大腿骨斷骨或者骨折？如果你有多過一次概大腿骨斷骨或f 
骨折，請列出你每次斷髖骨時概年齡。 




Cj)有 〇有——• 去第I題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你Oj幾多歲槪時候患有膝關節斷骨或者骨折？如果你有多過一次嗽膝關節斷骨或者 
骨折，請列出你每次斷髖骨時概年齡。 
歲 歲 歲 
當時你概膝關節係點樣整斷當時你概膝關節係點樣整斷當時你概膝關節係點樣整斷 
架？ ^ m 
I有有醫生曾經話你患有小腿骨斷骨或者骨折？ 
〇 有 •有一““• 去第J題 
係邊類慨醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你晚幾多歲槪時候患有小腿骨斷骨或者骨折？如果你有多過一次概小腿骨斷骨或者-
骨折，請列出你每次斷髖骨時嚼年齡。 
I 歲 I 歲 I 歲 
當時你概小腿骨係點樣整斷當時你嚼小腿骨係點樣整斷當時你概小腿骨係點樣整斷 
架？ ^ ^ 




Cj)有 〇有——• 去第K題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你晚幾多歲槪時候患有腳、腳板或者腳祉骨斷骨或者骨折？如果你有多過一次概腳 
、腳板或者腳5(1:骨斷骨或者骨折，請列出你每次斷髖骨時概年齡。 
I 歲 I 歲 I 歲 
當時你概腳、腳板或者腳當時你概腳、腳板或者腳當時你概腳、腳板或者腳 
祉骨係點樣整斷架？ 祉骨係點樣整斷架？ 祉骨係點樣整斷架？ 
K有有醫生曾經話你患有手或者手指骨斷骨或者骨折？ 
〇 有 〇有——• 去第L題 
，f 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你晚幾多歲概時候患有手或者手指骨斷骨或者骨折？如果你有多過一次概手或者手 
iifi斷骨或者骨折，請列出你每次斷髖骨時概年齡。 
歲 歲 歲 
當時你概手或者手指骨係點當時你概手或者手指骨係點當時你概手或者手指骨係點 
樣整斷架？ 樣整斷架？ 樣整斷架？ 
L除佐以上概斷骨或者骨折，有有醫生曾經話你患有其他類別概骨折？ 
有 〇 冇 ~ • 去下一題 
係邊類概醫生？ 〇西醫 〇 中 醫 〇 跌 打 醫 生 
你Oi幾多歲概時候折斷這塊骨？如果你有多過一次概骨折，請列出你每次斷骨時概年 
齡。 
I 歲 I 歲 I 歲 
當時你係點樣整斷這塊骨當時你係點樣整斷這塊骨當時你係點樣整斷這塊骨 
架？ ^ 
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2.有有醫生曾經話你親生阿媽患有骨質疏鬆症？ 〇 有 〇 冇 〇 唔 知 道 
3.你親生阿媽有有試過斷骨或者骨折？ 〇 有 〇 有 〇 唔 知 道 
1 r 
I 有 丨 有 I 唔 
你親生阿媽有冇試過患有髖置骨折？ 〇 〇 〇 
你親生阿媽有有試過患有手腕或者前臂骨骨折？ 〇 〇 〇 
你親生阿媽有有試過患有脊椎骨折？ 〇 〇 〇 
除佐以上概骨折，你親生阿媽有有試過患有其他類 〇 〇 〇 
別概骨折？ I I I 
，r 
請註明： I 
4.你概親生阿媽係唔係仲在生？ 〇 係 〇唔係 〇唔知道 
你概•，生阿纟-依家幾多I你概親生！^媽，—候幾 
歲？ 歲 多歲？ 歲 
5.有tr醫生曾經話你親生阿爸患有骨質疏鬆症？ 〇 有 〇 有 〇 唔 知 道 
6.你親生阿爸有有試過斷骨或者骨折？ 〇 有 〇 冇 〇 唔 知 道 
I 有 I 有 I唔知道 
你親生阿爸有有試過患有髖骨骨@ 0 0 〇 
你親生阿爸有有試過患有手腕或者前臂骨骨折？ 〇 〇 〇 
你親生阿爸有有試過患有脊椎骨折？ 〇 〇 〇 
除佐以上嘲骨折，你親生阿爸有有試過患有其他類 〇 〇 〇 
別概骨折？ I I I 
請註明•• I 
7.你概親生阿爸係唔係仲在生？ 〇 係 〇唔係 〇唔知道 
你概•見生阿爸依家幾多I你概親生阿爸死n旣時候幾 
歲？ 歲 多歲？ 歲 
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1. Pf系過去12個月，你有行試過背痛？ 
有 〇有一去下一頁，第 6題 
，r 
临過去12個月，你有幾多時間受到背痛麟困擾？ 
〇全部時間 〇大部份時間 〇 有 些 時 間 〇 好 少 時 間 〇 完 全 有 
當你有背痛概時候，平均會有幾痛？ 
〇小小痛 〇幾痛 〇非常痛 
通常你背脊邊一個或者邊幾個部位痛？(訪問員請出示圖解及職所有痛概部位畫上X) 
〈、：、 — 
• 頸 〇上背 〇中背 〇腰背 〇臀部 
你概症狀會變得好u的、差_抑或喉一樣’當你： 
瞓喻床度？ 〇 好 卿 〇 差 啲 〇 一 樣 
坐喻張櫈度？ 〇 好 w 〇 差 啲 〇 一 樣 
企縣度？ 〇好D的 〇差卩的 〇一樣 
行緊路？ 〇好啲 〇差啲 〇一樣 
向前彎腰？(例如：彎低腰m) 〇好_ 〇差n的 〇一樣 
2.临過去12個月’你有有試過患有腰背痛？(訪問員請出示圖解） 
c p有 〇 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
你概腰背痛困擾你概程度有幾多？ 
〇完全有 〇少少困擾 〇中度困擾 〇極度困擾 
3.临過去12個月，你概背痛有冇試過痛到落臀部、髖骨、大腿、小腿或者隻腳？ 
c p有 〇 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 • 多 過 3 次 
呢一種徵狀困擾你概程度有幾多？ 
〇完全有 〇少少困擾 〇中度困擾 〇極度困擾 




有 〇 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你嚼程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
5.職過去12個月，你有背痛概時候有冇覺得你成隻大腿、小腿、足碟、或者隻腳， 
有軟弱無力概感覺？ 
c p有 • 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你概程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
6.脇過去12個月，你有冇試過患有頸痛？ 
有 〇 有 
，r 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你概程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
當你擔高個頭向上望概時候，你概頸痛會唔會變得好U的、差卩的抑或_一樣： 
〇好P的 〇差卩的 〇一樣 
7.職過去12個月，你概頸痛有冇試過痛到落隻手臂或者手掌？ 
有 〇 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過3次 
呢一種徵狀困擾你概程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
當你擔高個頭向上望職時候，你概頸痛會唔會變得好啲、差_抑或_一樣： 
〇 好 购 〇差D的 〇一樣 
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8.临過去12個月，你隻手臂或者手掌有有試過有麻痺或者針吉嘅感覺？ 
c p有 〇 有 
試過幾多次呀？ “ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你職程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
9.[瓶過去12個月，你隻手臂或者手掌有有試過軟弱無力？ 
有 〇 有 
試過幾多次呀？ “ 
〇 1 次 〇 2 至 3 次 • 多 過 3 次 
呢一種徵狀困擾你嘲程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
10.临過去12個月，你行路個陣有tr覺得自已唔夠靈活？ 
有 〇 有 
試過幾多次呀？ ~ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你概程度有幾多？ 
〇完全有 〇少少困擾 〇中度困擾 〇極度困擾 
11.啦過去12個月，你用雙手個陣有有覺得自已唔夠靈活？ 
有 〇 有 
試過幾多次呀？ 
〇 1 次 〇 2 至 3 次 〇多過 3次 
呢一種徵狀困擾你概程度有幾多？ 
〇 完 全 有 〇 少 少 困 擾 〇中度困擾 〇極度困擾 
12. Pf系過去12個月，你概活動有冇因爲背痛而受到限制？ 
有 〇 冇 
，F 
你有幾多曰會因爲背痛而要__床度最少半曰？ 
M i l日 
你有幾多曰會因爲背痛而限制或者減少你往常概活動？唔包括你__張床概日子。 
I I I I 日 
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13.要你彎低腰_地下執起一_輕概物件(例如：一件衫），你覺得有有困難？ 
有 〇 有 
，r 
對你曜講做呢個動作有幾難？ 




c p有 〇 有 
yr 
對你哦講做呢個動作有幾難？ 




有 〇 行 
對你哦講做呢個動作有幾難？ 




有 • 有 
對你哦講做呢個動作有幾難？ 




有 • 有 
，r 
對你曜講做呢個動作有幾難？ 
〇有些困難 〇好困難 〇 做 唔 到 
呢U的困難係唔係因爲背痛抑或其他原因？ 
〇係因爲背痛 〇係因爲其他原因 
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18.要你企大約兩個鐘頭，你覺得有冇困難？ 
有 • 冇 
對你哦講做呢個動作有幾難？ 




c p有 〇 有 
對你哦講做呢個動作有幾難？ “ 





有 〇 有 
口的痛職左髖關節，右髖關節抑或兩邊概髖關節？ 
〇左髖關節 〇右髖關節 〇兩邊概髖關節 
21.縣過去12個月，你任何一邊概膝關節概裏面或者週圍(包括膝關節概前、後、左、 
右)有有試過成日痛、痛或者覺得梗，而維持佐最少一個月？ 
Cj)有 〇 有 
，r 
U的痛略左膝關節，右膝關節抑或兩個膝關節？ 
〇 左 膝 關 節 〇右膝關節 〇兩個膝關節 




• 有 〇 有 
，r 
服用藥物種類： S S p S r a 
〇 Alpha-block 〇 〇 
〇 Androgen 〇 〇 
〇 Angiotensin converting enzyme 〇 〇 
(ACE) Inhibitor 
〇 Angiotensin II receptor antagonist 〇 〇 
O Antioandrogen 〇 〇 
O Antispasmodic, urinary 〇 〇 
〇Aspirin 〇 〇 
〇 Benzodiazepine 〇 〇 
〇 Beta-blocker 〇 〇 
O Calcium channel blocker 〇 〇 
O Cholinergic agonist 〇 〇 
〇 Corticosteroid, inhaled 〇 〇 
O Corticosteroid, oral 〇 O 
〇 Cox-II Inhibitor 〇 〇 
O Diuretic, loop 〇 〇 
O Diuretic, potassium-sparing 〇 〇 
O Diuretic, thiazide 〇 〇 
〇 Gemfibrozil 〇 〇 
O Histamine (H2) receptor antagonist 〇 〇 
〇 H M G CoA reductase inhibtor (statin) 〇 〇 
〇 Hypoglycemic agents 〇 〇 
o Narcotic analgesic 〇 〇 
〇Nitrate 〇 〇 
O Nonbenzodiazepine anticonvulsant 〇 〇 
〇 Nonsteroidal anti-inflammatory 〇 〇 
Agent (NSAID) 
〇 Proton pump inhibitor 〇 〇 
〇 Selective serotonin reuptake inhibitor 〇 〇 
(SSRI) 
〇 Sildenafil 〇 〇 
〇 Thyroid hormone 〇 〇 
〇 Traodone 〇 〇 
〇 Tricyclic 〇 〇 
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藥物使用-核對 
1.你每個月有有最少打一次男性激素(睪酮)？ 
有 〇 冇 
你每個月要接受幾多次男I你已經接受佐呢種治I你上次接受男性激素(睪酮)注射 
性激素(睪酮)概注射？ 療有幾多個月？ 概日期係幾時？ 
月 / 日 / 年 
口 次 I I I 月 n n r r n 
2.你每星期有有服用以下嘲藥物三次或以上？ 
核對 口述 有 
Aspirin (阿士匹靈） 
(This includes Bayer, baby aspirin, children's 〇 〇 〇 
aspirin, Ecotrin, Excedrin, and others) 
Acetaminophen (止痛藥) 
(This includes Tylenol, Tylenol with codeine, etc.) 〇 〇 〇 
Ibuprofm(布洛 % 
(This includes Advil, Motrin, and others) 〇 〇 〇 
Naproxen Sodium(甲氧丙酸） 
(This includes Aleve, etc.) 





Fluoride (or Sodium Fluoride)氟化物？ Calcitonin (or miacalcin)抑躬素？ 
(f)有 〇有 （p有 〇冇 
^ f W 
I你幾時開始服食Fluoride氟化物？ ||你幾時開始服食Calcitonin抑錦素？ 
B / ， ^ / ¥ 
你而家重有有經常服食Fluoride氟化物？ 你而家重有冇經常服食Calcitonin抑躬素？ 
〇有 Cj)有 〇有 cp有 
j • 
I你幾時開始停止服食Fluoride氟化物？ |你幾時開始停止服食Calcitonin抑躬素？ 
H _ / 年 月 / 年 
Appendix C 110 
藥物使用-核對 
Bisphosphonates(雙磷酸驢類)？ (This includes alendronate (Fosamax), clodronate， 
etidronate (Didronel), ibandronate, Pamidronate (Aredia), O W 〇 有 
Risedronate (Actonel) or tiludronate (Skelid) i 
I你幾時開始服食 i / ¥ 以下邊一種bisphosphonates(雙磷酸驢 
bisphosphonates 厂 " [ " ] 類 ) 你 曾 經 服 用 過 ？ （ 揀 所 有 合 適 概 答 案 ） 
(雙磷酸_類)？ ~ ~ 〇 Alendronate(Fosamax) 
〇 Clodronate 
你而家重有有經常服食 〇 有 〇 有 〇 Etidronate(Didronel) 
bisphosphonates ” 〇 Ibandronate 
(雙磷酸翻類)？ ^ P “ … 、 
71 0 Pamidronate(Aredia) 
你幾時開始停止服食 月 / 年 
bisphosphonates 〇 Risedronate(Actonel) 
(雙磷酸驢類）？ ~ 〇 Tiludronate(Skelid) 
〇其他/唔知道 
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香港中文大學 
The Chinese University of Hong Kong 
香港耆英骨質纖跟進計劃 
Mr Os/ MsOs Measurement Questionnaire 
測試問卷 
Participant's Name : 
Serial No ： © O O © 
o o o o 
© G O © © © © © 
O Q Q Q © © © © 
© O O © 
O O O O 
O O O © 
© G O © 
Date : Month / Day / Year 
© 0 © 0 0 © 
OO OO OO 
〇 © 0 © 〇 © 
〇 © 0 © 〇 © 
OO OO OO 
〇 © 〇 © 〇 © 
〇 © 〇 © 〇 © 
OO OO OO 
〇 © o © 〇 © 
〇 © 〇 © 〇 © 
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Blood Pressure 
量 度 細 
1. Exclusion criteria 
〇 Open wounds, ulcerations -> D O 
〇 Bilateral ampution N O T 
〇 Unable to lie at <45 degree angle -> TEST 
〇 Participant refused 
2. Cuff size 
〇 Small 〇 Regular 〇 Large 〇 Thigh 
3. Arm Used 
〇 Right 〇 Left 
i 
Please explain why right arm was not used: 
#Sitting Blood Pressure Systolic /Diastolic 
• • • / • • • m m H g 
4. Doppler Systolic • • • m m H g 
Add 30* *Add 30 to Doppler Systolic measurement to 
obtain maximal inflation level 
5. Maximum Inflation Level • • • m m H g 
Bp#l Systolic Bp #2 Systolic 
1. Brachial (arm) • • • m m H g 个 4. Brachial (arm) • • • m m H g 
2. Right Posterior Tibial • • • m m H g 5. Right Posterior Tibial • • • m m H g 
Left Posterior Tibial • • • m m H g 6. Left Posterior Tibial • • • m m H g 
Was the ankle-arm blood pressure obtained ？ 
o Yes 〇 No o Patient refused 
I 
W h y wasn't the measurement obtained ？ (Mark all that apply.) 
Left leg Right leg 
〇 Unable to occlude 〇 Unable to occlude 
〇 Ulceration 〇 Ulceration 
〇 Amputation 〇 Amputation 
〇 Unable to locate tibial artery 〇 Unable to locate tibial artery 
〇 Other. Please specify: 〇 other. Please specify: 
#Question No. 3 has been modified - "Sitting Blood Pressure Systolic Diastolic" 
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Grip Strength 
握力 
Exclusion Criteria : 
1. "Has any pain or arthritis in your hands gotten worse recently?“ 
〇 Yes O No 〇 Refused 〇 Don't Know 
i 
Which side ？ 〇 Left 〇 Right 〇 Both 
i i i 
IDO NOT IDO NOT IDO NOT TEST 
TEST LEFT TEST RIGHT EITHER SIDE 
1. "Have you had any surgery on your hands or wrists in the past 3 months(12 weeks) ？“ 
O Yes 〇 No 
i 
Which side ？ 〇 Left 〇 Right 〇 Both 
i i i 
IDO NOT IDO NOT IDO NOT TEST 
TEST LEFT TEST RIGHT EITHER SIDE 
Script: "I'd like you to take your right/left arm, rest it on the table and bend your elbow. Grip the bars 
in your hand, like this. Please slowly squeeze the bars as hard as you can." 
Hand the dynamometer to the participant. Adjust if needed. 
Script: "Now try it once just to get the feel of it. For this practice, just squeeze gently. It won't feel 
like the bars are moving, but your strength will be recorded. Are the bars the right distance apart for a 
comfortable grip?" 
Show dial to participant. 
Script: "We'll do this two times. This time counts, so when I say squeeze, squeeze as hard as you can. 
Ready? Squeeze! Squeeze! Now, Stop!，’ 
Right side Left side 
Trail 1 • • kg Trail 1 • • kg 
〇 Refused 〇 Refused 
〇 Unable, did not attempt 〇 Unable, did not attempt 
Trail 2 • • kg Trail 2 • • kg 
〇 Refused 〇 Refused 
〇 Unable, did not attempt 〇 Unable, did not attempt 
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Height, Weight & Pulse 
身高，體重’脈搏 
1. Standing Height 
Measurement 1 • • • • m m 
Measurement 2 • • • • m m 
Is the difference between Measurement land Measurement 2 > 4 m m ？ 
〇 Y e s 〇 N o 
i 
Complete Measurements 3 & 4 
Measurements 3 • • • • m m 
Measurements 4 • • • • m m 
Is the participant standing sideways due to kyphosis ？ 
〇 Y e s 〇 N o 
2. Weight • • • . • k g 
3. Radial Pulse 
Measurement 1 
• • • beats per 30 secondsx2 一 Measurement 1 ••口 beats per minute 
Measurement 2 
• • • beats per 30 secondsx2 Measurement 2 • • • beats per minute 
Total(Measurement 1+ Measurement 2) • • • +2 = • • • Average beats per minute 
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DXA雙能量X光吸收測量儀 
Bone Density Form骨質密度表 
1. Have you ever had a hip replacement surgery where all or part of your joint was replaced ？ 
〇 Yes O No 〇 Refused 
i 
, Scan right hip 
On which side did you have hip replacement surgery ？ 
〇 Right 〇 Left 
^ I 
Scan left hip Scan right hip 
2. Do you have any metal objects in your body such as a pacemaker, stapes, screws, plates，etc. ？ 
〇 Yes O No 〇 Don't know 〇 Refused 
i 
a. Flag scan for review by D X A reading Center. 
b. Indicate the location of the joint replacement, hardware or other artifacts. (Sub regions are 
those defined by the whole body scan analysis.) 
Sub Hardware ？ Other Artifacts ？ 
i. Head 〇 〇 
ii. Left arm 〇 〇 
iii. Right arm 〇 〇 
iv. Left ribs 〇 〇 
V. Right ribs 〇 〇 
vi. Thoracic spine 〇 〇 
vii. Lumbar spine 〇 〇 
vi. Pelvis 〇 〇 
ix. Left leg 〇 〇 
X. Right leg 〇 〇 
3. Have you had any of the following in the past ten days ？ Yes No 
a. Barium enema 〇 * 〇 
b. Upper GI X-ray series 〇 * 〇 
c. Lower GI X-ray series 〇 * 〇 
d. Nuclear medicine scan 〇 * 〇 
e. Other tests using contrast ('dye') or radioactive materials 〇 * 〇 
•Examiner note: If "Yes" to any responses above, reschedule bone density measurement so that at 
least 10 days will have passed since the tests were performed. 
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DXA雙能量X光吸收測量儀 
Bone Density Form骨質密度表 
4. Was a bone density measurement obtained for 
a. Whole body ？ 
〇 Y e s 〇 N o 
i 
Last 2 characters of scan ID# : • • 
Date of scan ： • • / • • / • • • • 
Month Day Year 
b. Hip ？ 
〇 Y e s 〇 N o 
1 
Last 2 characters of scan ID # : •口 
Date of scan ： • • / • • / • • • • 
Month Day Year 
Which hip was scanned ？ 〇 Right 〇 Left 
C. Spine ？ 
〇 Y e s 〇 N o 
i 
Last 2 characters of scan ID # : • • 
Date of scan ： • • / • • / • • • • 
Month Day Year 
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Neuromuscular Function 神經机肉功倉g 
Introduction / screening questions 簡介/普查問題 
1. Ask the participant, "Do you have any problems from recent surgery, injury or other 
health conditions that might prevent you from you standing straight up from a chair or 
walking up steps?" 
O Yes ~ • Tell the particpant, "Before we do each test, I'll describe it to you. Please tell me if 
〇 No you think you shouldn't attempt the test because of the problems you described." 
.2. Ask the participant, "Do you use walking aids, such as a cane ？ 
〇 No aids 〇 Cane or quad cane 〇 Walk, Wheelchair, leg brace, crutches 
3. Does the participant have any of the following ？〔 Mark all that apply〕 
〇 Orthosis 〇 Missing Limbs 〇 Prosthesis 〇 Paralysis of extremity or side of 
body 
Single Chair Stand 坐立測試 
1. Could the participant stand up one time unassisted ？ 
〇 Stands without using arms 〇 Unable to stand 〇 Rises using arms 〇 Did not 
attempt/Refused 
i i i 
Do not test the repeated chair stands. Go on to six meter usual pace, next page. 
Repeated Chair Stand重覆坐立測試 
5. Did the participant complete all 5 stands ？ 
〇 Y e s 〇 N o 
i 
H o w many were completed ？ • stands Go on to Six meter Usual Pace, next section 
—> 
6. Record time and arm use for chair stand. 
] • . • • (seconds to complete 5 stands) 
Arm use : 〇 5 times without using arms 〇 Attempted, but unable to stand up once 
〇 5 times, uses arms part of time 〇 Attempted, but unable to complete 5 
stands 
〇 5 times, uses arms all of time 〇 Did not attempt/Refused 
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Neuromuscular Function 神經机肉功倉g 
Six Meter Usual Pace六米步伐測試 
Trial 1 
1. O Trial 1 Not Attempted Trial 1 Aid Used 
〇 Trial 1 Attempted but unable 〇 No aid 〇 Walker 
〇 Unable to assess 〇 Straight cane 〇 Crutch 
_ __ _ 〇 Quad cane 
_II_I.I_II__ seconds • • steps 
Trail 2 
2. O Trial 1 Not Attempted Trial 2 Aid Used 
〇 Trial 1 Attempted but unable 〇 No aid 〇 Walker 
〇 Unable to assess 〇 Straight cane 〇 Crutch 
__ 〇 Quad cane 
_ _I.I__ __ seconds _ _ steps 
20 cm N A R R O W W A L K 20 厘米線內行 
Trial 1 (Narrow walk) 
1. Did the participant stay within the lines ？ Trial 1 Aid Used 
〇 Yes,2< deviations 〇 No,3 > deviations (Unable to assess time)〇 No aid 〇 Walker 
〇 Trial 1 Not Attempted 〇 Trial 1 Attempted but unable 〇 Straight cane 〇 Crutch 
I I I I I I ~ 〇 Quad cane 
_ __I.I__ __ seconds 
Trial 2 (Narrow walk) 
2. Did the participant stay within the lines ？ Trial 2 Aid Used 
O Yes,2< deviations O No,3 > deviations (Unable to assess time)〇 No aid 〇 Walker 
〇 Trial 1 Not Attempted 〇 Trial 1 Attempted but unable 〇 Straight cane 〇 Crutch 
__ _ _ __ 〇 Quad cane 
I Q . L J __ seconds 
Perform trial 3 only if Trial 1 or Trial 2 were labeled 'No, 3 > deviations (Unable to assess 
time)' 
Trial 3 (Narrow walk) 
3. Did the participant stay within the lines ？ Trial 3 Aid Used 
〇 Yes,2< deviations 〇 No,3 > deviations (Unable to assess time)〇 No aid 〇 Walker 
〇 Trial 1 Not Attempted 〇 Trial 1 Attempted but unable 〇 Straight cane 〇 Crutch 
〇 Quad cane 
] • . • [ _ ! seconds 
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X-Ray 
1. Did the participant have a thoracic spine x-ray ？ 
〇 Y e s 〇 N o 
i 
Date of thoracic spine film : • • / • • / • • • • 
Month Day Year 
2. Did the participant have a lumbar spine x-ray ？ 
〇 Y e s 〇 N o 
i 
Date of lumbar spine film ： • • / • • / • • • • 
Month Day Year 
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* Please insert Label * 
V J 
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病歷 
1.你有有曾經做過髖關節換骸手術？ 
〇有，右邊 •有，左邊 〇 有 〇我不知道 
] [ y 
那年: 那年: 
2.临過去12個月，你有有跌倒,地下或者跌倒概時候撞倒物件好似枱或者櫈？ 
• 有 〇 有 
，r 
職過去12個月，你總共跌倒過幾多次？（只揀一個答案) 
〇 1 次 
〇 2 至 3 次 







• 有 • 冇 
,, • Traumatic 








( A ) 躬 片 〇 有 〇 有 
，r 
(i) Regular…份量: 每日幾多粒： 食卩左幾耐: (年） 
(ii) Irregular 
( B )其他 〇 有 • 有 
1 r 
請列出你依家每日所食概藥物及補充劑。 
西藥/中藥/ffl充劑名 是否經醫生處方 你食佐幾耐 
p T | 〇 是 〇 否 
b； O ^ 
f； 〇 是 o ^ 
^ 〇 是 o ^ 
h； O S ^ 
I 〇 是 o ^ 
• . . 
> 
• •. • • . 
C U H K L i b r a r i e s 
0 0 4 5 0 6 5 9 1 
